Table 5. Incidence of medical and surgical adverse events in cataract surgery.
|
Outpatient preoperative evaluation |
Crude OR (95% CI) | Adjusted OR (95% CI)a | |||
|---|---|---|---|---|---|
| Total n=968 | YES (n=240) | NO (n=728) | |||
| Perioperative event | 355 (36.7) | 80 (33.8) | 275 (38.6) | 0.8 (0.59–1.10) | 0.6 (0.42–0.93) |
| Clinical | |||||
| Hypertension | 319 (33) | 71 (29.7) | 248 (34.0) | 0.8 (0.59–1.11) | 0.6 (0.41–0.93) |
| Bronchospasm | 1 (0.1) | 0 | 1 (0.1) | — | — |
| Arrhythmia | 0 | 0 | 0 | — | — |
| MACE | 0 | 0 | 0 | — | — |
| Ophthalmic | |||||
| Posterior capsule rupture | 70 (7.4) | 22 (9.2) | 48 (6.6) | 1.4 (0.83–2.39) | 1.1 (0.55–2.27) |
| Endophthalmitis | 5 (0.7) | 1 (0.4) | 4 (0.6) | 1.3 (0.14–11.7) | 1.7 (0.14–20.1) |
| Postoperative event | |||||
| 7-day emergency/hospitalization | 12 (1.3) | 3 (1.3) | 9 (1.3) | 1.0 (0.27–3.78) | 0.8 (0.14–4.71) |
Abbreviations: MACE, major adverse cardiovascular events; OR, odds ratio.
There was more than one event per patient.
a
Covariate adjustment using the propensity score (age, sex, hypertension, coronary artery disease, congestive heart failure, arrhythmia, history of stroke/transient ischemic attack, diabetes, creatinine ≥2 mg/dl, and pulmonary disease).